Lipocine Inc. financial data

Symbol
LPCN on Nasdaq
Location
Salt Lake City, United States
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 993% % -30%
Debt-to-equity 11% % 48%
Return On Equity -59% % -151457%
Return On Assets -53% % -146575%
Operating Margin -525% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7,299,687 shares 36%
Common Stock, Shares, Outstanding 6,158,443 shares 15%
Entity Public Float $16,400,000 USD -62%
Common Stock, Value, Issued $8,944 USD 0.91%
Weighted Average Number of Shares Outstanding, Basic 5,448,871 shares 2.1%
Weighted Average Number of Shares Outstanding, Diluted 5,708,238 shares 5.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,976,677 USD
Research and Development Expense $8,583,919 USD 17%
General and Administrative Expense $3,764,137 USD -25%
Operating Income (Loss) $10,371,379 USD -798%
Nonoperating Income (Expense) $744,074 USD -36%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $9,627,305 USD -106679%
Income Tax Expense (Benefit) $200 USD 0%
Net Income (Loss) Attributable to Parent $9,627,505 USD -115372%
Earnings Per Share, Basic -1.77 USD/shares
Earnings Per Share, Diluted -1.69 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,205,842 USD -16%
Cash, Cash Equivalents, and Short-term Investments $14,900,000 USD
Assets, Current $16,877,566 USD -24%
Property, Plant and Equipment, Net $104,293 USD -37%
Other Assets, Noncurrent $23,753 USD 0%
Assets $17,005,612 USD -24%
Accounts Payable, Current $971,822 USD 258%
Accrued Liabilities, Current $1,236,374 USD 34%
Liabilities, Current $2,528,196 USD 67%
Liabilities $2,528,196 USD 67%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,445 USD -51%
Retained Earnings (Accumulated Deficit) $209,396,367 USD -4.8%
Stockholders' Equity Attributable to Parent $14,477,416 USD -31%
Liabilities and Equity $17,005,612 USD -24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,969,257 USD -182%
Net Cash Provided by (Used in) Financing Activities $8,100 USD
Net Cash Provided by (Used in) Investing Activities $882,073 USD 78%
Common Stock, Shares Authorized 75,000,000 shares 0%
Common Stock, Shares, Issued 6,158,779 shares 15%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,851,330 USD -69%
Deferred Tax Assets, Valuation Allowance $51,046,307 USD 5.9%
Deferred Tax Assets, Gross $51,052,526 USD 5.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $9,632,198 USD -94247%
Lessee, Operating Lease, Liability, to be Paid $449,591 USD 2.5%
Property, Plant and Equipment, Gross $1,388,372 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two $64,452 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $385,139 USD 2.5%
Additional Paid in Capital $223,901,106 USD 1.4%